Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2012
07/18/2012CN102586285A Delta-endotoxin gene and usage method thereof
07/18/2012CN102586280A Yunnan red pear delta PyTTG1 gene, prokaryotic expression vector thereof and application of prokaryotic expression vector
07/18/2012CN102586276A 通过操作信使rna前体加工而提供的针对环境毒性的保护 By operating messenger rna precursor processing and provides protection against environmental toxicity
07/18/2012CN102586193A Monoclonal antibody for resisting duck tembusu virus, hybridoma strain and application thereof
07/18/2012CN102585010A Immunolatex microsphere for detecting rhbFGF (Recombinant Human Basic Fibroblast Growth Factor) and preparation method thereof
07/18/2012CN102585009A Monoclonal antibody, enzyme-linked immunosorbent assay (ELISA) method and kit for detecting chloramphenicol residues
07/18/2012CN102585008A Monoclonal antibody, enzyme-linked immunosorbent assay (ELISA) method and kit for detecting Sudan red I and para red
07/18/2012CN102585007A Monoclonal antibody, enzyme-linked immunosorbent assay (ELISA) method and kit for detecting beta-carotene pigments
07/18/2012CN102585006A Monoclonal antibody, enzyme-linked immunosorbent assay (ELISA) method and kit for detecting neomycin, amikacin and paromomycin
07/18/2012CN102585005A Monoclonal antibody and ELLSA (Enzyme Linked Immunosorbent Assay) method for detection of methyl-3-quinoxaline-2-carboxylic acid (MQCA), and kit
07/18/2012CN102585004A AEG-1 (Astrocyte Elevated Gene-1)/1E3 monoclonal antibody with high affinity
07/18/2012CN102585003A Preparation method and application of tumor-targeted photosensitive immunoconjugate
07/18/2012CN102585002A High affinity antibodies to human il-6 receptor
07/18/2012CN102585001A Anti-mn antibodies and methods of using same
07/18/2012CN102585000A Tumor marker CD25 autoantibody and application thereof
07/18/2012CN102584999A Human VEGFR-1 (Vascular Endothelial Growth Factor Receptor-1) targeting genetically engineered lymphocyte as well as preparation method and application thereof
07/18/2012CN102584998A Canine thymic stromal lymphopoietin protein and uses thereof
07/18/2012CN102584997A Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
07/18/2012CN102584996A Diagnostic agent for mesothelioma, diagnosis kit for mesothelioma, and diagnosis method for mesothelioma
07/18/2012CN102584995A Monoclonal antibody resistant to human phosphodiesterase 4D interaction protein variant 5 and application thereof
07/18/2012CN102584994A Egg yolk antibody for curing colibacillosis and preparation method thereof
07/18/2012CN102584993A High-titer human tetanus immunological blood plasma and preparation process thereof
07/18/2012CN102584992A Colon bacillus outer membrane protein monoclonal antibody and preparation method and application thereof
07/18/2012CN102584991A Novel egg-yolk antibody for Newcastle disease treatment and preparation method thereof
07/18/2012CN102584990A Method for extracting binary high-immunity yolk antibodies against newcastle disease and avian influenza
07/18/2012CN102584989A Methods and kits for dissociating Fc[gamma]-receptor-igg complexes and for IgG purification and detection
07/18/2012CN102584984A Artificially synthesized cinnamaldehyde complete antigen and application thereof
07/18/2012CN102584978A Marker for diagnosis and prognosis of colorectal cancer, breast cancer and pancreatic cancer
07/18/2012CN102584957A Specific antibody of Brucella specificity multi-epitope artificial polypeptide, immunomagnetic beads coated with specific bodies, and application of beads
07/18/2012CN102584949A Pc-C polypeptide inhibiting aspergillus fumigatus from adhering to cornea
07/18/2012CN102584947A Antibodies directed against hepatitis c virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
07/18/2012CN102580088A Egg yolk antibody for treating porcine circovirus disease and method for producing compound thereof
07/18/2012CN102060927B Monoclonal antibody capable of specifical recognization and activation of Galphaz protein and preparation method thereof
07/18/2012CN102060926B Monoclonal antibody for specifically identifying activated protein Gao and preparation method thereof
07/18/2012CN101870731B Polyclone antibody of H-9201, and preparation method and application thereof
07/18/2012CN101812129B Monoclonal antibody for hand-foot-mouth EV71 virus and application thereof
07/18/2012CN101735318B Cell strain, monoclonal antibody and kit for detecting tobacco rattle virus
07/18/2012CN101538307B Dehydroepiandrosterone hapten, artificial antigen and antibody as well as preparation method and application thereof
07/18/2012CN101531717B Anti-Alzheimer disease monoclonal antibody and application thereof
07/18/2012CN101511871B Anti-myostatin antibodies
07/18/2012CN101240022B Cell proliferation inhibitors containing anti-glypican 3 antibody
07/18/2012CN101098890B Fc variants with altered binding to fcrn
07/18/2012CN101048511B Production of polypeptides
07/18/2012CN101039960B Chimeric and humanised monoclonal antibodies against interleukin-13
07/18/2012CN101023098B Method of detecting hepatitis B virus s antigen
07/18/2012CN101018809B Expression-enhanced polypeptides
07/17/2012US8222393 Using U7 polypeptide as diagnostic and therapeutic tool preventing and treating cell proliferative disorders
07/17/2012US8222392 Kit for detection of telomerase reverse transcriptase nucleic acids
07/17/2012US8222377 Antigen associated with rheumatoid arthritis
07/17/2012US8222376 KIR-binding agents and methods of use thereof
07/17/2012US8222375 Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
07/17/2012US8222374 IL-21 antagonists
07/17/2012US8222373 Humanized antibodies and compositions for binding sphingosine-1-phosphate
07/17/2012US8222201 Crystalline form of linaclotide
07/17/2012US8222188 Antibody libraries
07/17/2012US8222002 Human anti-amyloid beta peptide antibody and fragment of said antibody
07/17/2012US8221988 Methods and compositions relating to CCR5 antagonist, IFN-γ and IL-13 induced inflammation
07/17/2012US8221769 Microorganisms for therapy
07/17/2012US8221768 Chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence
07/17/2012US8221759 Neutralizing monoclonal antibodies to respiratory syncytial virus
07/17/2012US8221757 Monoclonal antibodies against extracellular loops of C5aR
07/17/2012US8221756 Complement inhibitors and uses thereof
07/17/2012US8221755 Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ralpha1)
07/17/2012US8221754 Antihuman α9 integrin antibody and use of the same
07/17/2012US8221753 Endoglin antibodies
07/17/2012US8221752 Antibodies against human interleukin-13 and uses therefor
07/17/2012US8221751 Tumor-targeting monoclonal antibodies to FZD10 and uses thereof
07/17/2012US8221750 Single chain antibodies against β-amyloid peptide
07/17/2012US8221748 Compositions and methods for the systemic treatment of arthritis
07/17/2012CA2642146C Xrec2 dnas and polypeptides
07/17/2012CA2433514C T1r taste receptors and genes encoding same
07/17/2012CA2408174C Hcv core protein sequences
07/17/2012CA2391392C Methods for screening candidate drugs that disrupt mif and jab1 interaction, mif and jab1 complex, antibodies and uses thereof
07/17/2012CA2355976C Vascular endothelial cell growth factor antagonists and uses thereof
07/17/2012CA2277486C Synthetic antibiotics
07/17/2012CA2266325C A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
07/12/2012WO2012094587A1 Plasma kallikrein binding proteins
07/12/2012WO2012094252A1 Anti-hla-e antibodies, therapeutic immunomodulatory antibodies to human hla-e heavy chain, useful as ivig mimetics and methods of their use
07/12/2012WO2012093732A1 Antibody to signal peptide of amyloid precursor protein
07/12/2012WO2012093706A1 Method for preparing antigen to obtain antihydrophobic peptide antibody
07/12/2012WO2012093704A1 Method for improving physical properties of antibody
07/12/2012WO2012093172A1 Alphabodies specifically binding to cytokines or growth factors and/or cytokine or growth factor receptors
07/12/2012WO2012093127A2 Modulators of il-12 and/or il-23 for the prevention or treatment of alzheimer's disease
07/12/2012WO2012093125A1 Ligands that bind tgf-beta receptor ii
07/12/2012WO2012093013A1 Alphabodies specifically binding to class-i viral fusion proteins and methods for producing the same
07/12/2012WO2012092971A1 Alphabodies specifically binding to viral proteins and methods for producing the same
07/12/2012WO2012092970A1 Alphabody libraries and methods for producing the same
07/12/2012WO2012092665A1 Method for facilitating tissue transplantation
07/12/2012WO2012092664A1 Monoclonal anti-anti-mhc antibodies and uses thereof
07/12/2012WO2012092663A1 Monoclonal anti-anti-anti-mhc antibodies and uses thereof
07/12/2012WO2012071216A3 Antibodies for tumor gangliosides
07/12/2012WO2012065055A3 Fusion proteins for hiv therapy
07/12/2012WO2012056407A8 Antibodies which bind soluble t-cell receptor ligands
07/12/2012WO2012051170A3 Imaging of meningiomas using phingylbenzothiazole, stilbene, or biphenylalkyne derivatives
07/12/2012WO2012031280A3 Identification and enrichment of cell subpopulations
07/12/2012WO2012018790A4 Dual variable domain immunoglobulins and uses thereof
07/12/2012WO2011054359A8 Method for early detection of cancer using o - glycosylated mucin peptides or corresponding monoclonal antibodies
07/12/2012US20120178912 RECEPTOR ACTIVATOR OF NF-kappaB
07/12/2012US20120178911 Genes with es cell-specific expression
07/12/2012US20120178910 Cation exchange chromatography (methods)
1 ... 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 ... 1494